ES544234A0 - Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos - Google Patents

Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos

Info

Publication number
ES544234A0
ES544234A0 ES544234A ES544234A ES544234A0 ES 544234 A0 ES544234 A0 ES 544234A0 ES 544234 A ES544234 A ES 544234A ES 544234 A ES544234 A ES 544234A ES 544234 A0 ES544234 A0 ES 544234A0
Authority
ES
Spain
Prior art keywords
tidinone
aze
procedure
production
substituted compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544234A
Other languages
English (en)
Other versions
ES8604209A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58048989A external-priority patent/JPS59225182A/ja
Priority claimed from JP58221469A external-priority patent/JPS60115577A/ja
Priority claimed from JP58221470A external-priority patent/JPS60115578A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES8604209A1 publication Critical patent/ES8604209A1/es
Publication of ES544234A0 publication Critical patent/ES544234A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES85544234A 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos Expired ES8604209A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP58048989A JPS59225182A (ja) 1983-03-25 1983-03-25 ２−アゼチジノン−４−カルボン酸の誘導体
JP58221469A JPS60115577A (ja) 1983-11-25 1983-11-25 ２−アゼチジノン−４−置換体
JP58221470A JPS60115578A (ja) 1983-11-25 1983-11-25 ２−アゼチジノン−４−置換化合物

Publications (2)

Publication Number Publication Date
ES8604209A1 ES8604209A1 (es) 1986-01-16
ES544234A0 true ES544234A0 (es) 1986-01-16

Family

ID=27293483

Family Applications (4)

Application Number Title Priority Date Filing Date
ES530960A Granted ES530960A0 (es) 1983-03-25 1984-03-23 Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos
ES85544234A Expired ES8604209A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos
ES544235A Expired ES8604208A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos.
ES544236A Expired ES8604136A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES530960A Granted ES530960A0 (es) 1983-03-25 1984-03-23 Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES544235A Expired ES8604208A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-azetidinona 4-sustituidos.
ES544236A Expired ES8604136A1 (es) 1983-03-25 1985-06-14 Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos

Country Status (8)

Country Link
US (3) US4564609A (es)
EP (1) EP0123444B1 (es)
KR (3) KR870000357B1 (es)
CA (1) CA1256650A (es)
DE (1) DE3476399D1 (es)
DK (1) DK164684A (es)
ES (4) ES530960A0 (es)
NO (1) NO158740C (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719207A (en) * 1984-06-25 1988-01-12 Yamanouchi Pharmaceutical Co., Ltd. CNS active substituted azetidinone compounds
JPS6253994A (ja) 1985-05-09 1987-03-09 Yamanouchi Pharmaceut Co Ltd １−置換シリル−４−オキソ−２−アゼチジンカルボン酸低級アルキルエステル
ZA868957B (en) * 1985-12-06 1987-07-29 Yamanouchi Pharma Co Ltd Crystals of nalpha-(((s)-4-oxo-2-azetidinyl)carbonyl)-l-histidyl-l-prolinamide and process for producing the crystals
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
DK437289D0 (da) * 1989-09-04 1989-09-04 Hans Bundgaard Prodrug derivatives of thyrotropin-releasing hormone (trh)
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
JP2001524132A (ja) * 1997-05-09 2001-11-27 スミスクライン・ビーチャム・コーポレイション ＣｏＡ−ＩＴのベータ−ラクタム阻害剤
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
JP4812225B2 (ja) * 2000-07-11 2011-11-09 塩野義製薬株式会社 生理活性ペプチド含有腸溶性製剤
KR100557268B1 (ko) 2000-08-31 2006-03-07 시오노기세이야쿠가부시키가이샤 파킨슨씨병 치료제
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
SK9502003A3 (en) * 2001-01-26 2003-12-02 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
PT1385548E (pt) * 2001-01-26 2007-08-24 Schering Corp Combinações de um inibidor ou de inibidores de absorção de esteróis com agente (s) para o tratamento de doenças vasculares
WO2002058733A2 (en) * 2001-01-26 2002-08-01 Schering Corporation Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
AR035533A1 (es) * 2001-01-26 2004-06-02 Schering Corp Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
IL156445A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
WO2002058685A2 (en) * 2001-01-26 2002-08-01 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
ES2275007T3 (es) * 2001-05-25 2007-06-01 Schering Corporation Uso de derivados de azetidinona sustitudos en el tratamiento de la enfermedad de alzeimer.
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
HUP0401501A3 (en) * 2001-09-21 2012-02-28 Schering Corp Treating or preventing vascular inflammation using pharmaceutical compositions containing sterol absorption inhibitor(s)
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
MXPA04002573A (es) * 2001-09-21 2004-06-18 Schering Corp Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol.
WO2004043457A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
CA2517572C (en) * 2003-03-07 2011-12-13 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
JP2006519869A (ja) * 2003-03-07 2006-08-31 シェーリング　コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
EP1601668B1 (en) * 2003-03-07 2008-08-27 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP2007510659A (ja) * 2003-11-05 2007-04-26 シェーリング　コーポレイション 脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
KR101137503B1 (ko) * 2009-07-14 2012-04-20 웰이앤씨 주식회사 고분자 고체 지지체를 이용한 히스티딜-프롤린아미드 유도체의 제조 방법
RU2652187C2 (ru) * 2013-08-16 2018-04-25 ЛОС АЛАМОС НЭШНЛ СЕКЬЮРИТИ, ЭлЭлСи Композиции и способы для улучшения продуктивности растений

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
US4271164A (en) * 1979-04-16 1981-06-02 Warner-Lambert Company 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4426378A (en) * 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant

Also Published As

Publication number Publication date
EP0123444B1 (en) 1989-01-25
KR880009549A (ko) 1988-09-15
ES8604209A1 (es) 1986-01-16
DE3476399D1 (en) 1989-03-02
KR870000357B1 (ko) 1987-03-05
ES544236A0 (es) 1986-01-16
DK164684A (da) 1984-09-26
ES544235A0 (es) 1986-01-16
US4564609A (en) 1986-01-14
KR840008021A (ko) 1984-12-12
ES8600279A1 (es) 1985-10-01
NO841158L (no) 1984-09-26
ES8604208A1 (es) 1986-01-16
EP0123444A1 (en) 1984-10-31
ES8604136A1 (es) 1986-01-16
KR890002104B1 (ko) 1989-06-19
US4636567A (en) 1987-01-13
DK164684D0 (da) 1984-03-23
US4610821A (en) 1986-09-09
NO158740C (no) 1988-10-26
ES530960A0 (es) 1985-10-01
CA1256650A (en) 1989-06-27
NO158740B (no) 1988-07-18
KR890002105B1 (ko) 1989-06-19
KR880009550A (ko) 1988-09-15

Similar Documents

Publication Publication Date Title
ES544236A0 (es) Un procedimiento para la produccion de compuestos de 2-aze- tidinona 4-sustituidos
ES538836A0 (es) Un procedimiento para la produccion de imagenes
ES509658A0 (es) Un procedimiento para la produccion de un derivado de carbostirilo
ES551507A0 (es) Un procedimiento para la produccion de compuestos de fenetanolamina
ES532455A0 (es) Un procedimiento para la produccion de un derivado de catecol
ES541386A0 (es) Un procedimiento para la preparacion de un compuesto
ES548222A0 (es) Un procedimiento para la produccion de un derivado de diami-das de n-acilaminoacidos
ES499401A0 (es) Un procedimiento para la produccion de compuestos de tria- ril-metano
ES533735A0 (es) Procedimiento para la produccion de espirosuccinimidas
ES529851A0 (es) Un procedimiento para la produccion de triptofano
ES530153A0 (es) Un procedimiento para la preparacion de compuestos de beta-lactama
ES543999A0 (es) Un procedimiento para la produccion de dihidropiridinas
ES538115A0 (es) Procedimiento para la produccion de acilamino-s-triacinas sustituidas
ES529850A0 (es) Un procedimiento para la produccion de histidina
ES548939A0 (es) Un procedimiento para la produccion de dimetilamina
ES526050A0 (es) Un procedimiento para la produccion de glutation
ES536603A0 (es) Un procedimiento para la produccion de un poliuretano
ES527205A0 (es) Procedimiento para la produccion de compuestos poliazoicos
ES538365A0 (es) Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas.
ES535494A0 (es) Un procedimiento para la preparacion de un compuesto de b-lactama
MX157830A (es) Procedimiento para la produccion de beta-fenilserina
BR8305366A (pt) Metodo para a producao de l-fenil-alanina
ES545608A0 (es) Procedimiento para la fabricacion de nuevos compuestos cina-moicos
ES531528A0 (es) Un procedimiento para la preparacion de un compuesto
ES530664A0 (es) Un procedimiento para la produccion de compuestos poliprenilicos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303